Table 9.
AUCs in the 2 combined predicted models using various growth definitions of HE.
| AUC (TST+BT) | P-value | AUC (TST+BT+EC) | P-value | Improvement | |
|---|---|---|---|---|---|
| >6 mL | 0.710 (0.672–0.747) | <0.001 | 0.724 (0.688–0.759) | <0.001 | 2.0% |
| >12.5 mL | 0.710 (0.662–0.758) | <0.001 | 0.731 (0.686–0.778) | <0.001 | 3.0% |
| >33% | 0.620 (0.575–0.665) | <0.001 | 0.675 (0.635–0.715) | <0.001 | 8.9% |
| >6 mL or >33% | 0.668 (0.629–0.707) | <0.001 | 0.690 (0.653–0.727) | <0.001 | 3.3% |
| >12.5 mL or >33% | 0.642 (0.601–0.684) | <0.001 | 0.679 (0.639–0.720) | <0.001 | 5.8% |
AUC, area under the receiver operating characteristic curve; HE, hematoma expansion; TST, time from symptom onset to initial CT; BV, baseline ICH volume; EC, eosinophil count.